by Heather Gillman | Oct 17, 2025 | News, Press Releases
Phase Advance and QNova Capital Forge Alliance to Usher in AI-Driven, Non-Animal Drug Development Era Predictive AI modeling startup and biotech-focused venture fund unite to accelerate next-generation therapeutics and reshape the FDA regulatory path. SAN DIEGO, CA,...
by Heather Gillman | Sep 3, 2025 | News, Press Releases
Aiming to Accelerate Market Launch with a Track Record of 100% FDA Approval Success August 26 , 2025—OrganTech Inc. (Head Office: Chuo-ku, Tokyo; CEO: Yoshio Shimo; hereinafter “OrganTech”), engaged in the world’s first application of organ regeneration technology* to...
by Heather Gillman | May 13, 2025 | News, Press Releases
Columbia, MD — May 13, 2025 QNova LifeSciences and Liberi Group are pleased to announce the signing of an exclusive agreement to provide mutual referral consultancy services, effective May 1, 2025. This strategic collaboration reflects both organizations’ commitment...
by Heather Gillman | Jan 5, 2025 | News, Press Releases
We’re excited to announce that QNova LifeSciences is now doing business as QNova LifeSciences. While our name has changed, our commitment to excellence in FDA regulatory guidance remains the same. This rebrand reflects our mission to accelerate the development of...
by Heather Gillman | Nov 25, 2024 | News, Press Releases
Cambridge, MA & Columbia, MD — November 26, 2024 — Trifermed, founded in 2002, a strategic partnership company empowering health innovators to transform ideas into impactful solutions, and CSSi LifeSciences, a leading U.S.- based regulatory consulting and...
by Heather Gillman | Apr 18, 2024 | News, Press Releases
As a leader in US FDA MedTech regulatory affairs, we understand the complexities and challenges you face in bringing groundbreaking medical technologies from concept to market. In our continuous quest to provide unparalleled support to innovators like you, CSSi...
Recent Comments